Literature DB >> 4040936

Prolactin pulsatility in polycystic ovarian disease.

T Laatikainen, A Tulenheimo.   

Abstract

Secretion patterns of LH and prolactin were studied in 5 nonobese (group A) and 7 obese (group B) women with polycystic ovaries (PCO) by taking blood samples at 15-min intervals for 6 h. Serum LH level showed a distinct pulsatility in all patients. There was no significant difference in the mean pulse rate of LH between group A (6.2 +/- 0.45, mean +/- SE) and group B (5.8 +/- 0.24). A pulsatile secretion pattern in prolactin was also found in 11 of the 12 PCO patients studied, the pulse rate being 3.2 +/- 1.0 in group A and 3.9 +/- 0.45 in group B. 79% of prolactin pulses coincided with those of LH but their amplitude was significantly lower than that of LH. In the total group of PCO patients a positive correlation was found between the serum concentrations of prolactin and free estradiol (r = 0.85), and prolactin and estrone (r = 0.78) indicating that estrogens participate in the regulation of prolactin secretion in polycystic ovarian disease. Four patients showed a steep decrease in the plasma prolactin level at the beginning of the study period suggesting a sensitive stress response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040936     DOI: 10.1007/BF03350674

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Familial study of hirsutism.

Authors:  E Moncada
Journal:  J Clin Endocrinol Metab       Date:  1970-11       Impact factor: 5.958

2.  The apparent free testosterone concentration, an index of androgenicity.

Authors:  A Vermeulen; T Stoïca; L Verdonck
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

3.  Failure of oral water loading and intravenous hypotonic saline to suppress plasma prolactin in man.

Authors:  R A Adler; G L Noel; L Wartofsky; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

Review 4.  The polycystic ovary syndrome.

Authors:  S S Yen
Journal:  Clin Endocrinol (Oxf)       Date:  1980-02       Impact factor: 3.478

5.  Pulsatile secretion of LH, FSH, prolactin, oestradiol and progesterone during the human menstrual cycle.

Authors:  C T Bäckström; A S McNeilly; R M Leask; D T Baird
Journal:  Clin Endocrinol (Oxf)       Date:  1982-07-01       Impact factor: 3.478

6.  Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.

Authors:  R Rebar; H L Judd; S S Yen; J Rakoff; G Vandenberg; F Naftolin
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

7.  On the correlation of luteinizing hormone-releasing hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin levels in plasma of women with normal menstrual cycles.

Authors:  S Aksel
Journal:  Am J Obstet Gynecol       Date:  1981-10-15       Impact factor: 8.661

8.  The hyperprolactinemic polycystic ovary syndrome may not be an distinct entity.

Authors:  B Corenblum; P J Taylor
Journal:  Fertil Steril       Date:  1982-11       Impact factor: 7.329

9.  Concomitant pulsatile release of prolactin and luteinizing hormone in hypogonadal women.

Authors:  N S Cetel; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

10.  Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO.

Authors:  R A Lobo; L Granger; U Goebelsmann; D R Mishell
Journal:  J Clin Endocrinol Metab       Date:  1981-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.